Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ABFex-M
- Development stage
- Unknown
- Lead developer
- Ind Blues Pharma
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
ABFex-M is an oral fixed-dose combination therapy developed by Ind Blues Pharma for the management of chronic respiratory and allergic conditions, including asthma, chronic obstructive pulmonary disease (COPD), and allergic bronchitis. It is formulated as a tablet containing three active ingredients: acebrophylline (a mucolytic and bronchodilator), fexofenadine (a selective peripheral H1-receptor antagonist), and montelukast (a cysteinyl leukotriene receptor antagonist). Together, these components work synergistically to relax airway smooth muscle, reduce mucus viscosity, and inhibit allergic inflammatory pathways, thereby improving breathing and controlling allergy-related airway symptoms.
- Brand names
- ABFex-MAbfex-M Tablet SR
- Other names
- acebrophylline + fexofenadine + montelukast
02
Targets
PDE4 (Phosphodiesterase 4A1)CYSLTR1 (Cysteinyl-leukotriene type 1 receptor)HRH1 (Histamine H1 Receptor)
Beyond the preview
Go deeper on ABFex-M.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ABFex-M.